ZYLAPINE ODT olanzapine 5 mg orally disintegrating tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

olanzapine, Quantity: 5 mg

Saadav alates:

Arrotex Pharmaceuticals Pty Ltd

Ravimvorm:

Tablet, orally disintegrating

Koostis:

Excipient Ingredients: microcrystalline cellulose; polacrilin potassium; aspartame; mannitol; crospovidone; sodium stearylfumarate; colloidal anhydrous silica; Flavour

Manustamisviis:

Oral

Ühikuid pakis:

7, 28

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

ZYLAPINE ODT is indicated for the treatment of schizophrenia and related psychoses. ZYLAPINE ODT alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ZYLAPINE ODT for preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Toote kokkuvõte:

Visual Identification: Yellow coloured, circular, flat faced beveled edge tablets debossed with 'C' on one side and '51' on the other side; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2017-11-03